A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1161, doi. 10.1007/s40273-024-01431-6
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 10
Results: 7
1
2
Unravelling Elements of Value of Healthcare and Assessing their Importance Using Evidence from Two Discrete-Choice Experiments in England.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1145, doi. 10.1007/s40273-024-01416-5
- By:
- Publication type:
- Article
3
Proxy Preferences and the Values of Children's Health States.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1065, doi. 10.1007/s40273-024-01415-6
- By:
- Publication type:
- Article
4
Systematic Review of Economic Evaluations of Systemic Treatments for Advanced and Metastatic Gastric Cancer.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1091, doi. 10.1007/s40273-024-01413-8
- By:
- Publication type:
- Article
5
Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission–Economic Evaluation Model.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1111, doi. 10.1007/s40273-024-01412-9
- By:
- Publication type:
- Article
6
Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1073, doi. 10.1007/s40273-024-01406-7
- By:
- Publication type:
- Article
7
Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 10, p. 1127, doi. 10.1007/s40273-024-01400-z
- By:
- Publication type:
- Article